Survodutide Dosage Guide
Clinical Trials
Written by Alejandro Reyes
Founder & Lead Researcher
PN
Reviewed by Peptide Nerds Editorial · Updated April 2026
Not medical advice. Dosage information is provided for educational purposes based on published research.
Always consult a qualified healthcare provider before starting any protocol. Full disclaimer.
Dosage overview
| Typical dose | 0.6 mg to 4.8 mg weekly |
| Frequency | Once weekly |
Dosing notes
Phase 3 dosing not yet finalized.
Important safety information
Dosage ranges listed above are based on available research data and reported protocols. Individual dosing should be determined by a qualified healthcare provider based on your specific health profile, goals, and response to treatment.
- Start at the lowest effective dose and titrate up gradually
- Monitor for side effects, especially during dose increases
- Do not exceed researched dose ranges without medical supervision
Research references
- Survodutide for Obesity (Phase 2) — New England Journal of Medicine (2024) [PubMed]
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.